You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

bemcentinib

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer of Pancreas Trial in Dallas (Bemcentinib, Nab-paclitaxel, Gemcitabine)

Terminated
  • Cancer of Pancreas
  • Bemcentinib
  • +3 more
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Sep 26, 2022

NSCLC Trial (Bemcentinib, Pembrolizumab, Pemetrexed)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Bemcentinib
  • +3 more
  • (no location specified)
Jul 19, 2022

NSCLC Trial in United States (erlotinib, bemcentinib)

Completed
  • Non-Small Cell Lung Cancer
  • Los Angeles, California
  • +9 more
Aug 16, 2022

Brain and CNS Tumors Trial in United States (BGB 324 (before surgery), BGB 324 (after surgery))

Active, not recruiting
  • Brain and Central Nervous System Tumors
  • BGB 324 (before surgery)
  • BGB 324 (after surgery)
  • Birmingham, Alabama
  • +5 more
Dec 1, 2022

Acute Myeloid Leukemia, High-risk Myelodysplastic Syndrome, Low-risk Myelodysplastic Syndrome Trial in France, Germany,

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • Bemcentinib
  • Nantes, Nantes Cedex 1, France
  • +7 more
Dec 20, 2021

COVID-19 Trial in India, South Africa (Bemcentinib, SoC)

Completed
  • COVID-19
  • Bemcentinib
  • SoC
  • Surat, Gujarat, India
  • +11 more
Oct 13, 2021

Acute Myeloid Leukemia, MDS Trial in Worldwide (Bemcentinib, Cytarabine, Decitabine)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Bemcentinib
  • +2 more
  • Iowa City, Iowa
  • +11 more
Mar 1, 2022

Mesothelioma, Malignant Trial in Leicester (Rucaparib, Abemaciclib, pembrolizumab & bemcentinib)

Recruiting
  • Mesothelioma, Malignant
  • Leicester, United Kingdom
    University Hospitals of Leicester NHS Trust
Apr 6, 2022